NB
Norinchukin Bank Portfolio holdings
AUM
$6.72B
This Quarter Return
+8.61%
1 Year Return
+19.37%
3 Year Return
+81.53%
5 Year Return
+130.2%
10 Year Return
+300.21%
AUM
$5.96B
AUM Growth
+$5.96B
(+17%)
Cap. Flow
+$482M
Cap. Flow
% of AUM
8.08%
Top 10 Holdings %
Top 10 Hldgs %
46.07%
Holding
558
New
1
Increased
432
Reduced
119
Closed
5
Top Buys
| 1 |
Apple
AAPL
|
$40.4M |
| 2 |
Microsoft
MSFT
|
$28.5M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
$24.3M |
| 4 |
Visa
V
|
$19.1M |
| 5 |
Mastercard
MA
|
$16.1M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$170M |
| 2 |
Roper Technologies
ROP
|
$17.4M |
| 3 |
Exxon Mobil
XOM
|
$9.86M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$9.46M |
| 5 |
Copart
CPRT
|
$6.56M |
Sector Composition
| 1 | Technology | 18.56% |
| 2 | Healthcare | 10.08% |
| 3 | Financials | 8.14% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Schlumberger
SLB
$53.6B
| $9.66M | 0.16% |
196,692
+79,178
| +67% | +$3.89M |
|
102
Elevance Health
ELV
$72.6B
| $9.51M | 0.16% |
21,403
+5,740
| +37% | +$2.55M |
|
103
Vertex Pharmaceuticals
VRTX
$103B
| $9.44M | 0.16% |
26,829
+6,622
| +33% | +$2.33M |
|
104
AT&T
T
$208B
| $9.3M | 0.16% |
583,053
+139,133
| +31% | +$2.22M |
|
105
Analog Devices
ADI
$122B
| $8.84M | 0.15% |
45,396
+7,483
| +20% | +$1.46M |
|
106
Danaher
DHR
$146B
| $8.71M | 0.15% |
36,303
-12,340
| -25% | -$2.96M |
|
107
Stryker
SYK
$149B
| $8.59M | 0.14% |
28,171
+7,141
| +34% | +$2.18M |
|
108
Mondelez International
MDLZ
$80B
| $8.57M | 0.14% |
117,494
+17,275
| +17% | +$1.26M |
|
109
T-Mobile US
TMUS
$288B
| $8.56M | 0.14% |
61,646
+9,254
| +18% | +$1.29M |
|
110
EOG Resources
EOG
$68.8B
| $8.33M | 0.14% |
72,757
+33,139
| +84% | +$3.79M |
|
111
Tyler Technologies
TYL
$23.9B
| $8.26M | 0.14% |
19,822
+17,122
| +634% | +$7.13M |
|
112
Pool Corp
POOL
$11.4B
| $8.15M | 0.14% |
21,748
+1,844
| +9% | +$691K |
|
113
PayPal
PYPL
$66.2B
| $8.12M | 0.14% |
121,742
+45,188
| +59% | +$3.02M |
|
114
CSX Corp
CSX
$60B
| $8.1M | 0.14% |
237,446
+68,012
| +40% | +$2.32M |
|
115
Lam Research
LRCX
$123B
| $8.05M | 0.14% |
12,519
+1,970
| +19% | +$1.27M |
|
116
CVS Health
CVS
$94B
| $7.92M | 0.13% |
114,519
+29,204
| +34% | +$2.02M |
|
117
Regeneron Pharmaceuticals
REGN
$61.3B
| $7.89M | 0.13% |
10,985
+2,568
| +31% | +$1.85M |
|
118
Charles Schwab
SCHW
$174B
| $7.71M | 0.13% |
135,977
+52,540
| +63% | +$2.98M |
|
119
Synopsys
SNPS
$110B
| $7.7M | 0.13% |
17,674
+2,509
| +17% | +$1.09M |
|
120
Linde
LIN
$222B
| $7.6M | 0.13% |
19,945
-3,386
| -15% | -$1.29M |
|
121
Cigna
CI
$80.3B
| $7.59M | 0.13% |
27,047
+7,068
| +35% | +$1.98M |
|
122
Equinix
EQIX
$75.5B
| $7.52M | 0.13% |
9,596
+808
| +9% | +$633K |
|
123
Citigroup
C
$174B
| $7.42M | 0.12% |
161,151
+55,839
| +53% | +$2.57M |
|
124
Union Pacific
UNP
$132B
| $7.32M | 0.12% |
35,762
+831
| +2% | +$170K |
|
125
Chubb
CB
$110B
| $7.04M | 0.12% |
36,569
+14,485
| +66% | +$2.79M |
|